Skip to main content Skip to navigation

Identifying Myc target genes (direct and indirect) involved in key features of pancreatic islet tumourigenesis

This presentation was given together with Stella Pelengaris.

The c-Myc oncogene is overexpressed or deregulated in many human cancers, and is often associated with aggressive, poorly differentiated tumours. c-Myc encodes a transcription factor, the onco-protein c-MYC, that acts as a master regulator of genes involved in diverse cellular processes, such as cellular replication and growth, apoptosis, loss of cellular differentiation, invasion, and angiogenesis. Despite being a key regulator of cell replication, it is now widely accepted that c-MYC can also act as its own tumour suppressor by promoting cell death (apoptosis). Thus, for putative cancer cells to arise, apoptosis must be blocked.

The generation of conditional (c-MycERTAM) transgenic mice, which allow regulated activation of c-Myc in distinct tissues (skin epidermis and pancreatic islets), have highlighted which cellular responses predominate in adult tissues in vivo. The c-MycERTAM transgene is targetted to the β-cells in the pancreatic islets of Langerhans by putting expression under the control of the insulin promoter. Activation of the transcribed chimeric protein, through administartion of the specific ligand 4-HydroxyTamoxifen (4OHT), results in a massive apoptotic response. However, suppression of apoptosis by the inclusion of a second transgene, the anti-apoptotic BclXL, results in a massive growth response and the production of large hyperplastic tumours - insulinoma.

Discussed here is a study of c-Myc induced target genes involved in pancreatic islet tumourigenesis using a large scale microarray based approach. The presentation can be found here.

Sam Robson

Contact Me:


S dot C dot Robson at warwick dot ac dot uk


MOAC Doctoral Training Centre
Coventry House
University of Warwick